Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Muscle Relaxant Drug Market Forecasts to 2034 – Global Analysis By Drug Type (Neuromuscular Blocking Agents, Skeletal Muscle Relaxant Drugs and Facial Muscle Relaxant Drugs), Dosage Form (Capsule, Tablet, Liquid, Sprays and Gel and Ointments), Route Of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Muscle Relaxant Drug Market is accounted for $4.7 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 6.3% during the forecast p...
April 2026
200 pages
Myasthenia Gravis Disease Treatment Market Forecasts to 2034 – Global Analysis By Type (Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Transient Neonatal Myasthenia Gravis and Other Types), Drug Class (Cholinesterase Inhibitors, Monoclonal Antibodies, Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins and Other Drug Classes), Treatment Modality, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Myasthenia Gravis Treatment Market is accounted for $2.8 billion in 2026 and is expected to reach $5.4 billion by 2034 growing at a CAGR of 8.5% during the for...
April 2026
200 pages
Paresthesia Treatment Market Forecasts to 2034 – Global Analysis By Type (Chronic Paresthesia, Acute Paresthesia and Other Types), Treatment (Tropical Creams, Anticonvulsants, Immunosuppressant, Antivirals and Other Treatments), Cause, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paresthesia Treatment Market is accounted for $6.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 5.6% during the forecast...
April 2026
200 pages
Paronychia Treatment Market Forecasts to 2034 – Global Analysis By Product (Mupirocin Ointment, Gentamicin Ointment, Fusidic Acid Ointment, Dicloxacillin and Other Products), Type (Chronic Paronychia, Acute Paronychia, Pyogenic Paronychia, Candidal Paronychia and Other Types), End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Paronychia Treatment Market is accounted for $660.6 million in 2026 and is expected to reach $1335.8 million by 2034 growing at a CAGR of 9.2% during the forec...
April 2026
200 pages
Pharmaceutical Sterility Testing Market Forecasts to 2034 – Global Analysis By Product (Instruments and Kits & Reagents), Test Type (Container Closure Integrity Testing, Sterility Testing, Bacterial Endotoxin Testing, Fluorescent Labeling, Rapid Micro Test and Other Test Types), Service, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Pharmaceutical Sterility Testing Market is accounted for $2.3 billion in 2026 and is expected to reach $6.3 billion by 2034 growing at a CAGR of 13.4% during t...
April 2026
200 pages
Turner Syndrome Market Forecasts to 2034 – Global Analysis By Type (Mosaic Turner Syndrome and Classical Turner Syndrome), Drug Type (Oxandrolone, Oxandrin, Norditropin, Somatropin, Genotropin, Humatrope, Zomacton and Nutropin), Therapy Type, Diagnosis, Route Of Administration, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Turner Syndrome Market is accounted for $5.3 billion in 2026 and is expected to reach $9.8 billion by 2034 growing at a CAGR of 8.1% during the forecast period...
April 2026
200 pages
Urinary Tract Infection Market Forecasts to 2034 – Global Analysis By Product (Azoles and Amphotericin B, Cephalosporin, Nitrofurans, Penicillin and Combinations, Quinolones and Other Products), Treatment Type, Test Type, Indication, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Urinary Tract Infection Market is accounted for $8.2 billion in 2026 and is expected to reach $14.9 billion by 2034 growing at a CAGR of 7.67% during the forec...
April 2026
200 pages
UK Cardiovascular Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design Interventional, Observational), By Indication (Stroke, Cardiac Arrhythmias, Heart Failure), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The UK cardiovascular clinical trials market size was estimated at USD 507.8 million in 2025 and is projected to reach USD 892.2 million by 2033, growing at a CAGR of 7.6% from 2026 to 2033. he market...
April 2026
140 pages
Small Molecule API CDMO Market Size, Share & Trends Analysis Report By Drug (Innovators, Generics), By Application (Cardiovascular Diseases, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, Infectious Diseases), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global small molecule API CDMO market size was valued at USD 46.59 billion in 2025 and is projected to reach USD 80.74 billion by 2033, growing at a CAGR of 7.28% from 2026 to 2033. The market is...
April 2026
200 pages
Hyperlocal E-Pharmacy Delivery Market Forecasts to 2034 – Global Analysis By Type of Service (Prescription Medications, Over?the?Counter (OTC) Drugs, Healthcare & Wellness Products, and Diagnostic Services), Delivery Model, Channel, Payment Mode, Technology, Customer Type and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Hyperlocal E-Pharmacy Delivery Market is accounted for $44.5 billion in 2026 and is expected to reach $198.6 billion by 2034 growing at a CAGR of 20.5% during...
April 2026
200 pages
Investigator Payment Management Solutions Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment (Cloud-based, On-premise), By Functionality, By End Use, By Payment, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global investigator payment management solutions market size was estimated at USD 492.02 million in 2025 and is projected to reach USD 1338.1 million by 2033, growing at a CAGR of 13.5% from 2026...
April 2026
150 pages
Randomization And Trial Supply Management Market Size, Share & Trends Analysis Report By Delivery Mode (Cloud & Web-based, On-premise), By End-use (Hospitals, CROs, Academic Institutes, Pharma & Biotech Organizations), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global randomization and trial supply management (RTSM) market size was estimated at USD 791.6 million in 2025 and is projected to reach USD 2083.8 million by 2033, growing at a CAGR of 13.0% from...
April 2026
120 pages
Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis And DMPK studies, Toxicology Testing, Compound Management), By Development Stage, By Indication, By Model, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... the forecast period. North America is expected to dominate preclinical CRO market over the forecast period owing to local presence of established ... the region in the global preclinical trial outsourcing market. Some of the key players in the preclinical CRO market are Charles River Laboratories International, ...
April 2026
120 pages
Appetite Stimulant Market Size, Share & Trends Analysis Report By Pharmacological Class (Cannabinoids & CNS-Acting Agents, Anabolic & Metabolic Agents), By Indication, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global appetite stimulant market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.90 billion by 2033, growing at a CAGR of 6.76% from 2026 to 2033. The market address...
April 2026
150 pages
U.S. Vaccines Market Size, Share & Trends Analysis Report By Indication (Viral, Bacterial, Cancer Vaccines, Allergy), By Type (Subunit, Inactivated), By Payer Type, By Age Group, By Use Populations, By Usage/Administration Pattern, By Sales, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The U.S. vaccines market size was estimated at USD 26.00 billion in 2025 and is projected to reach USD 40.19 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The U.S. vaccines market is...
April 2026
150 pages
Solid Dosage Form Market Forecasts to 2034 – Global Analysis By Dosage Form (Tablets, Capsules, Powders & Granules, Lozenges & Pastilles, Pellets & Mini-Tablets, Orally Disintegrating Films, and Other Dosage Forms), Drug Release, Route of Administration, Therapeutic Area, Manufacturing Process, Drug Type, Patient Demographics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Solid Dosage Form Market is accounted for $1113.6 billion in 2026 and is expected to reach $1856.9 billion by 2034 growing at a CAGR of 6.6% during the forecas...
April 2026
200 pages
Preventive Vaccine Market 20262033
US$ 2,999.00
The Preventive Vaccine Market was valued at in and is anticipated to reach US$ 118.36 billion by 2033, at a CAGR of 0.084 from 2026 to 2032. The report delivers in-depth insights into key market dynam...
April 2026
200 pages
Congenital Adrenal Hyperplasia Treatment Market - 2025
US$ 2,999.00
The Congenital Adrenal Hyperplasia Treatment Market was valued at US$ 0.27 billion in 2025 and is anticipated to reach by , at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insights...
April 2026
219 pages
Congenital Hyperinsulinism Treatment Market - 2025
US$ 2,999.00
The Congenital Hyperinsulinism Treatment Market was valued at USD 171.9 million in 2025 and is anticipated to reach by , at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights int...
April 2026
200 pages
Neurofibromatosis Type 2 Market 2026
US$ 2,999.00
The Neurofibromatosis Type 2 Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
April 2026
218 pages
Pneumococcal Vaccines Market - 2025-2033
US$ 2,999.00
The Pneumococcal Vaccines Market was valued at US$ 8.73 billion in 2025 and is anticipated to reach US$ 13.02 billion by 2033, at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insigh...
April 2026
217 pages
UK Pharmacy Automation Systems Market - 2024-2033
US$ 2,999.00
The UK Pharmacy Automation Systems Market was valued at US$ 435.78 million in 2024 and is anticipated to reach US$ 755.72 million by 2033, at a CAGR of 0.07 from 2026 to 2032. The report delivers in-d...
April 2026
220 pages
Charcot-Marie-Tooth (CMT) Disease Market - 2025-2033
US$ 2,999.00
The Charcot-Marie-Tooth (CMT) Disease Market was valued at US$ 746.99 Million in 2025 and is anticipated to reach US$ 1,166.98 Million by 2033, at a CAGR of 0.058 from 2026 to 2032. The report deliver...
April 2026
220 pages
Compartment Syndrome Treatment Market - 2025-2033
US$ 2,999.00
The Compartment Syndrome Treatment Market was valued at US$ 356.7 million in 2025 and is anticipated to reach US$ 583.2 million by 2033, at a CAGR of 0.063 from 2026 to 2032. The report delivers in-de...
April 2026
210 pages
Epidural Abscess Treatment Market - 2025-2033
US$ 2,999.00
The Epidural Abscess Treatment Market was valued at USD 52.65 billion in 2025 and is anticipated to reach USD 105.12 billion by 2033, at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth...
April 2026
218 pages
Limb-Girdle Muscular Dystrophy Market - 2023-2031
US$ 2,999.00
The Limb-Girdle Muscular Dystrophy Market was valued at US$ 1.3 billion in 2023 and is anticipated to reach US$ 2.4 billion by 2031, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth...
April 2026
217 pages
Opioid Induced Constipation Treatment Market - 2025-2033
US$ 2,999.00
The Opioid Induced Constipation Treatment Market was valued at US$ 1,241.90 million in 2025 and is anticipated to reach US$ 1,835.00 million by 2033, at a CAGR of 0.05 from 2026 to 2032. The report de...
April 2026
217 pages
Global Eletriptan Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... are 15 Chapters to deeply display the global Eletriptan market. Chapter 1, to describe Eletriptan Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
April 2026
88 pages
Global Vinca Alkaloid API Market Growth 2026-2032
US$ 3,660.00
The global Vinca Alkaloid API market size is predicted to grow from US$ 130 million in 2025 to US$ 214 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032. Vinca alkaloids are...
April 2026
116 pages
Global Pharma Grade Ethyl Oleate Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Ethyl Oleate market size is predicted to grow from US$ 40.46 million in 2025 to US$ 62.09 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Ethyl Ole...
April 2026
104 pages
Global Polypeptide API Market Growth 2026-2032
US$ 3,660.00
The global Polypeptide API market size is predicted to grow from US$ 8387 million in 2025 to US$ 15420 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032. Polypeptide API is t...
April 2026
134 pages
